A clinical study on siddha trial drug kana nei in children having Bronchial asthma

An open clinical study on sooli kanam (Bronchial asthma) in children to evaluate the efficacy of siddha trial drug kana nei

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015381

Enrollment

Registered

2018-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system Health Condition 2: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Kana nei: 2gm twice a day for 21 days as internal medicine Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Cough without expectoration Dyspnoea Running nose Chest tightness Wheezing

Exclusion criteria

Exclusion criteria: Primary complex Pneumonia Lung abcess Cystic fibrosis Bronchiolitis

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptoms like (cough,wheeze, dyspnea) Reduction in PASS scoreTimepoint: Nil	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDrShanmuga priya

Government siddha medical college, Arumbakkam, Chennai

dr.shanmugapriyaa.km@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026